Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial-Reference-Cited by-同舟云学术

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

Published:2015-08 Issue:8 Volume:16 Page:897-907
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Soria Jean-Charles,Felip Enriqueta,Cobo Manuel,Lu Shun,Syrigos Konstantinos,Lee Ki Hyeong,Göker Erdem,Georgoulias Vassilis,Li Wei,Isla Dolores,Guclu Salih Z,Morabito Alessandro,Min Young J,Ardizzoni Andrea,Gadgeel Shirish M,Wang Bushi,Chand Vikram K,Goss Glenwood D

Publisher

Elsevier BV

Subject

Oncology

Reference37 articles.

1. Pathology of lung cancer;Travis;Clin Chest Med,2011

2. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Reck;Ann Oncol,2014

3. Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy;Drilon;Lancet Oncol,2012

4. Current state-of-the-art therapy for advanced squamous cell lung cancer;Scagliotti;Am Soc Clin Oncol Educ Book,2013

5. Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer;Scagliotti;J Thorac Oncol,2011

Cited by 380 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory Trajectory and Anti-Inflammatory Pharmacotherapy in Frozen Elephant Trunk-Treated Acute Type I Aortic Dissection;Journal of the Society for Cardiovascular Angiography & Interventions;2024-07

2. Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications;Clinical Therapeutics;2024-06

3. Covalent drug – An emerging framework for targeted drug development;Results in Chemistry;2024-06

4. Afatinib‐induced toxic epidermal necrolysis: A case report with a literature review;British Journal of Clinical Pharmacology;2024-05-27

5. Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients—Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs;PharmacoEconomics - Open;2024-05-02